On Identifying and Mitigating Bias in the Estimation of the COVID-19 Case Fatality Rate
暂无分享,去创建一个
Rohit Varma | Anastasios Nikolas Angelopoulos | Reese Pathak | Michael I. Jordan | Michael I. Jordan | Reese Pathak | R. Varma
[1] J. Pedrosa,et al. Influenza Infectious Dose May Explain the High Mortality of the Second and Third Wave of 1918–1919 Influenza Pandemic , 2010, PloS one.
[2] Derek A T Cummings,et al. Estimating Absolute and Relative Case Fatality Ratios from Infectious Disease Surveillance Data , 2012, Biometrics.
[3] J. Ioannidis,et al. COVID-19 antibody seroprevalence in Santa Clara County, California , 2020, medRxiv.
[4] Roberto Maroldi,et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). , 2020, JAMA cardiology.
[5] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.
[6] F. Abad‐Franch,et al. Sex Bias in Infectious Disease Epidemiology: Patterns and Processes , 2013, PloS one.
[7] Jon Brassey,et al. SARS-CoV-2 viral load and the severity of COVID-19 , 2020 .
[8] Gerardo Chowell,et al. Mathematical and statistical estimation approaches in epidemiology , 2009 .
[9] R. Redfield,et al. Covid-19 — Navigating the Uncharted , 2020, The New England journal of medicine.
[10] M. Hernán,et al. Potential Biases in Estimating Absolute and Relative Case-Fatality Risks during Outbreaks , 2015, PLoS neglected tropical diseases.
[11] D. Cummings,et al. Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions , 2020, medRxiv.
[12] S. Holmberg,et al. Estimating acute viral hepatitis infections from nationally reported cases. , 2014, American journal of public health.
[13] W. Gong,et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. , 2020, JAMA cardiology.
[14] Novel Coronavirus Pneumonia Emergency Response Epidemiol Team. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.
[15] Samuel L Groseclose,et al. Evaluation of reporting timeliness of public health surveillance systems for infectious diseases , 2004, BMC public health.
[16] T L Chorba,et al. Mandatory reporting of infectious diseases by clinicians. , 1989, JAMA.
[17] Bradley Efron,et al. Censored Data and the Bootstrap , 1981 .
[18] Kazuyuki Aihara,et al. The Time Required to Estimate the Case Fatality Ratio of Influenza Using Only the Tip of an Iceberg: Joint Estimation of the Virulence and the Transmission Potential , 2012, Comput. Math. Methods Medicine.
[19] M. Battegay,et al. 2019-novel Coronavirus (2019-nCoV): estimating the case fatality rate - a word of caution. , 2020, Swiss medical weekly.
[20] J. Ioannidis,et al. Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters , 2020, Environmental Research.
[21] B. Gersh. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study , 2009 .
[22] Benjamin J Cowling,et al. Non‐parametric estimation of the case fatality ratio with competing risks data: an application to Severe Acute Respiratory Syndrome (SARS) , 2006, Statistics in medicine.
[23] Jarek Kobiela,et al. Estimating case fatality rates of COVID-19 , 2020, The Lancet Infectious Diseases.
[24] Matt J Keeling,et al. Contact tracing and disease control , 2003, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[25] Luna Yue Huang,et al. The Effect of Large-Scale Anti-Contagion Policies on the Coronavirus (COVID-19) Pandemic , 2020, medRxiv.
[26] Alison P Galvani,et al. Under-reporting and case fatality estimates for emerging epidemics , 2015, BMJ : British Medical Journal.
[27] Weier Wang,et al. Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China , 2020, Journal of medical virology.
[28] David J. Warne,et al. Hindsight is 2020 vision: a characterisation of the global response to the COVID-19 pandemic , 2020, BMC Public Health.
[29] C. Fraser,et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong , 2003, The Lancet.
[30] Michael I. Jordan. Graphical Models , 2003 .
[31] Michael M. Wagner,et al. Automatic Electronic Laboratory-Based Reporting of Notifiable Infectious Diseases , 2002, Emerging infectious diseases.
[32] N. Linton,et al. Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data , 2020, medRxiv.
[33] A. Siddique,et al. Cholera epidemic among Rwandan refugees: experience of ICDDR,B in Goma, Zaire. , 1994, Glimpse.
[34] J. Rocklöv,et al. The reproductive number of COVID-19 is higher compared to SARS coronavirus , 2020, Journal of travel medicine.
[35] Joshua M Sharfstein,et al. Diagnostic Testing for the Novel Coronavirus. , 2020, JAMA.
[36] Andrew Gelman,et al. Struggles with survey weighting and regression modeling , 2007, 0710.5005.
[37] K. Sliwa,et al. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study , 2008, The Lancet.
[38] Megan Andrew,et al. Longitudinal associations between poverty and obesity from birth through adolescence. , 2014, American journal of public health.
[39] C. Whittaker,et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis , 2020, The Lancet Infectious Diseases.
[40] E. Dong,et al. An interactive web-based dashboard to track COVID-19 in real time , 2020, The Lancet Infectious Diseases.
[41] H. Checkoway,et al. Epidemiologic programs for computers and calculators. Use of Poisson regression models in estimating incidence rates and ratios. , 1985, American journal of epidemiology.
[42] C. Ronco,et al. Kidney involvement in COVID-19 and rationale for extracorporeal therapies , 2020, Nature Reviews Nephrology.
[43] Per Block,et al. Demographic science aids in understanding the spread and fatality rates of COVID-19 , 2020, Proceedings of the National Academy of Sciences.
[44] N. Wilson,et al. Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality , 2020, Emerging infectious diseases.
[45] Hua Cai,et al. Sex difference and smoking predisposition in patients with COVID-19 , 2020, The Lancet Respiratory Medicine.
[46] Jarvis T. Chen,et al. U.S. county-level characteristics to inform equitable COVID-19 response , 2020, medRxiv.